Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 185
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Ir Med J ; 113(6): 101, 2020 06 11.
Artículo en Inglés | MEDLINE | ID: mdl-32816436

RESUMEN

This is the first documented case of an infant with congenital Zika virus infection (ZVI) born in Ireland. A term infant was delivered with an antenatal diagnosis of severe microcephaly. First trimester bloods confirmed maternal ZVI and although the infant did not have Zika virus RNA or Zika-specific IgM in her blood or urine, she had multiple clinical features of congenital ZVI and Zika virus RNA was present in the placenta.


Asunto(s)
Complicaciones Infecciosas del Embarazo/diagnóstico , Complicaciones Infecciosas del Embarazo/virología , Infección por el Virus Zika/congénito , Infección por el Virus Zika/diagnóstico , Virus Zika , Biomarcadores/análisis , Imagen de Difusión por Resonancia Magnética , Femenino , Humanos , Inmunoglobulina M/análisis , Lactante , Recién Nacido , Irlanda , Intercambio Materno-Fetal , Microcefalia/diagnóstico , Microcefalia/virología , Placenta/metabolismo , Placenta/virología , Embarazo , Primer Trimestre del Embarazo , Diagnóstico Prenatal , Efectos Tardíos de la Exposición Prenatal , ARN Viral/análisis , Índice de Severidad de la Enfermedad , Virus Zika/genética , Virus Zika/inmunología , Infección por el Virus Zika/virología
2.
Ann Oncol ; 29(1): 215-222, 2018 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-29045551

RESUMEN

Background: Radiotherapy is an effective treatment of intermediate/high-risk locally advanced prostate cancer, however, >30% of patients relapse within 5 years. Clinicopathological parameters currently fail to identify patients prone to systemic relapse and those whom treatment intensification may be beneficial. The purpose of this study was to independently validate the performance of a 70-gene Metastatic Assay in a cohort of diagnostic biopsies from patients treated with radical radiotherapy and androgen deprivation therapy. Patients and methods: A bridging cohort of prostate cancer diagnostic biopsy specimens was profiled to enable optimization of the Metastatic Assay threshold before further independent clinical validation in a cohort of diagnostic biopsies from patients treated with radical radiotherapy and androgen deprivation therapy. Multivariable Cox proportional hazard regression analysis was used to assess assay performance in predicting biochemical failure-free survival (BFFS) and metastasis-free survival (MFS). Results: Gene expression analysis was carried out in 248 patients from the independent validation cohort and the Metastatic Assay applied. Ten-year MFS was 72% for Metastatic Assay positive patients and 94% for Metastatic Assay negative patients [HR = 3.21 (1.35-7.67); P = 0.003]. On multivariable analysis the Metastatic Assay remained predictive for development of distant metastases [HR = 2.71 (1.11-6.63); P = 0.030]. The assay retained independent prognostic performance for MFS when assessed with the Cancer of the Prostate Assessment Score (CAPRA) [HR = 3.23 (1.22-8.59); P = 0.019] whilst CAPRA itself was not significant [HR = 1.88, (0.52-6.77); P = 0.332]. A high concordance [100% (61.5-100)] for the assay result was noted between two separate foci taken from 11 tumours, whilst Gleason score had low concordance. Conclusions: The Metastatic Assay demonstrated significant prognostic performance in patients treated with radical radiotherapy both alone and independent of standard clinical and pathological variables. The Metastatic Assay could have clinical utility when deciding upon treatment intensification in high-risk patients. Genomic and clinical data are available as a public resource.


Asunto(s)
Biopsia/métodos , Neoplasias de la Próstata/patología , Neoplasias de la Próstata/radioterapia , Anciano , Estudios de Cohortes , Supervivencia sin Enfermedad , Perfilación de la Expresión Génica , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Estadificación de Neoplasias , Modelos de Riesgos Proporcionales , Neoplasias de la Próstata/genética , Reproducibilidad de los Resultados , Estudios Retrospectivos , Medición de Riesgo/métodos , Factores de Riesgo
3.
Ir Med J ; 115(No.10): 687, 2022 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-36920552
4.
Epidemiol Infect ; 143(3): 461-9, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25306863

RESUMEN

We describe two cases of infant botulism due to Clostridium butyricum producing botulinum type E neurotoxin (BoNT/E) and a previously unreported environmental source. The infants presented at age 11 days with poor feeding and lethargy, hypotonia, dilated pupils and absent reflexes. Faecal samples were positive for C. butyricum BoNT/E. The infants recovered after treatment including botulism immune globulin intravenous (BIG-IV). C. butyricum BoNT/E was isolated from water from tanks housing pet 'yellow-bellied' terrapins (Trachemys scripta scripta): in case A the terrapins were in the infant's home; in case B a relative fed the terrapin prior to holding and feeding the infant when both visited another relative. C. butyricum isolates from the infants and the respective terrapin tank waters were indistinguishable by molecular typing. Review of a case of C. butyricum BoNT/E botulism in the UK found that there was a pet terrapin where the infant was living. It is concluded that the C. butyricum-producing BoNT type E in these cases of infant botulism most likely originated from pet terrapins. These findings reinforce public health advice that reptiles, including terrapins, are not suitable pets for children aged <5 years, and highlight the importance of hand washing after handling these pets.


Asunto(s)
Toxinas Botulínicas/análisis , Botulismo/diagnóstico , Botulismo/patología , Clostridium butyricum/aislamiento & purificación , Heces/química , Animales , Antitoxina Botulínica/uso terapéutico , Botulismo/terapia , Clostridium butyricum/clasificación , Clostridium butyricum/genética , Humanos , Recién Nacido , Masculino , Tipificación Molecular , Mascotas , Reptiles , Resultado del Tratamiento , Reino Unido , Microbiología del Agua
5.
Avian Pathol ; 44(6): 443-51, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26365395

RESUMEN

Avian Nephritis Virus (ANV) has been implicated in poor growth and renal disease of young chickens. This paper describes the development of a reverse-transcriptase polymerase chain reaction for the detection of ANV in commercial meat chickens and the use of high-resolution melt curves to detect the presence of genetically different ANVs. Pooled cloacal swabs from both healthy and ill commercial chicken broiler flocks were tested for the presence of ANV using a combination of polymerase chain reaction, molecular cloning, high-resolution melt curve analysis and sequencing. Except for one, all specimens were found to contain two genetically different ANVs. Phylogenetic analysis of the capsid amino acid sequences revealed the presence of four of six groups of ANV identified previously in other countries as well as in two novel groups of ANV. Phylogenetic analysis of nucleotide sequences of partial polymerase, capsid and 3' untranslated regions reveal that the genes of individual ANV virus isolates have different ancestors. This was shown to be due to a template-switching event in the capsid gene that resulted in the 3' end of the capsid gene and the 3' untranslated region of one ANV isolate being transferred to another ANV. These results reveal that infection of chicken flocks with multiple ANV isolates is common and this needs to be taken into consideration in diagnosis of ANV using molecular techniques and in future epidemiological investigations.


Asunto(s)
Infecciones por Astroviridae/veterinaria , Avastrovirus/genética , Pollos , Reacción en Cadena de la Polimerasa/veterinaria , Enfermedades de las Aves de Corral/virología , Regiones no Traducidas 3'/genética , Secuencia de Aminoácidos , Animales , Infecciones por Astroviridae/virología , Avastrovirus/aislamiento & purificación , Secuencia de Bases , Proteínas de la Cápside/genética , Coinfección/veterinaria , ADN Complementario/química , ADN Complementario/genética , Variación Genética , Datos de Secuencia Molecular , Filogenia , ARN Viral/genética , Análisis de Secuencia de ADN/veterinaria
6.
Nat Genet ; 24(4): 368-71, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10742099

RESUMEN

A goal of molecular genetics is to understand the relationship between basic nuclear processes, epigenetic changes and the numerous proteins that orchestrate these effects. One such protein, ATRX, contains a highly conserved plant homeodomain (PHD)-like domain, present in many chromatin-associated proteins, and a carboxy-terminal domain which identifies it as a member of the SNF2 family of helicase/ATPases. Mutations in ATRX give rise to characteristic developmental abnormalities including severe mental retardation, facial dysmorphism, urogenital abnormalities and alpha-thalassaemia. This circumstantial evidence suggests that ATRX may act as a transcriptional regulator through an effect on chromatin. We have recently shown that ATRX is localized to pericentromeric heterochromatin during interphase and mitosis, suggesting that ATRX might exert other chromatin-mediated effects in the nucleus. Moreover, at metaphase, some ATRX is localized at or close to the ribosomal DNA (rDNA) arrays on the short arms of human acrocentric chromosomes. Here we show that mutations in ATRX give rise to changes in the pattern of methylation of several highly repeated sequences including the rDNA arrays, a Y-specific satellite and subtelomeric repeats. Our findings provide a potential link between the processes of chromatin remodelling, DNA methylation and gene expression in mammalian development.


Asunto(s)
ADN Helicasas , Metilación de ADN , Proteínas de Unión al ADN/genética , Mutación , Proteínas Nucleares , Factores de Transcripción/genética , Southern Blotting , Islas de CpG/genética , Análisis Mutacional de ADN , ADN Ribosómico/genética , ADN Ribosómico/metabolismo , ADN Satélite/genética , Regulación hacia Abajo/genética , Técnica del Anticuerpo Fluorescente Indirecta , Globinas/biosíntesis , Globinas/genética , Humanos , Discapacidad Intelectual/genética , Secuencias Repetitivas de Ácidos Nucleicos/genética , Síndrome , Telómero/genética , Cromosoma X/genética , Proteína Nuclear Ligada al Cromosoma X , Talasemia alfa/genética
8.
Ir Med J ; 106(9): 277-8, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24416851

RESUMEN

Maple syrup urine disease (MSUD) has an incidence of 1:125,000 newborns in Ireland. Patients, when fasting, or in a catabolic state build up toxic metabolites leading to progressive neurological dysfunction. We describe the necessary peri-operative management of a patient with MSUD who developed symptomatic gallstones requiring a laparoscopic cholecystectomy.


Asunto(s)
Colecistectomía Laparoscópica , Cálculos Biliares/diagnóstico , Cálculos Biliares/etiología , Cálculos Biliares/cirugía , Enfermedad de la Orina de Jarabe de Arce/complicaciones , Pancreatocolangiografía por Resonancia Magnética , Femenino , Humanos , Pruebas de Función Hepática , Adulto Joven
9.
Am J Transplant ; 12(4): 1046-51, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22233157

RESUMEN

Dense deposit disease is a rare glomerulonephritis caused by uncontrolled stimulation of the alternative complement pathway. Allograft survival after kidney transplantation is significantly reduced by the high rate of disease recurrence. No therapeutic interventions have consistently improved outcomes for patients with primary or recurrent disease. This is the first reported case of recurrent dense deposit disease being managed with eculizumab. Within 4 weeks of renal transplantation, deteriorating graft function and increasing proteinuria were evident. A transplant biopsy confirmed the diagnosis of recurrent dense deposit disease. Eculizumab was considered after the failure of corticosteroid, rituximab and plasmapheresis to attenuate the rate of decline in allograft function. There was a marked clinical and biochemical response following the administration of eculizumab. This case provides the first evidence that eculizumab may have a place in the management of crescentic dense deposit disease. More information is necessary to clarify the effectiveness and role of eculizumab in dense deposit disease but the response in this patient was encouraging. The results of clinical trials of eculizumab in this condition are eagerly awaited.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Vía Alternativa del Complemento/efectos de los fármacos , Glomerulonefritis Membranoproliferativa/tratamiento farmacológico , Glomerulonefritis Membranoproliferativa/etiología , Trasplante de Riñón/efectos adversos , Prevención Secundaria , Adulto , Femenino , Glomerulonefritis/tratamiento farmacológico , Glomerulonefritis/etiología , Glomerulonefritis/patología , Glomerulonefritis Membranoproliferativa/patología , Humanos , Plasmaféresis , Pronóstico , Trasplante Homólogo
10.
Eye (Lond) ; 36(8): 1645-1650, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-34326494

RESUMEN

OBJECTIVES: This paper looks at patients with a diagnosis of tubulointerstitial nephritis and uveitis (TINU) presenting to the Northern Ireland regional adult and paediatric uveitis service in the Belfast Health and Social Care Trust. The demographic distribution, treatment required and the visual and renal outcomes of these patients are documented. METHODS: Data were collected retrospectively on 24 patients with TINU using the Northern Ireland Electronic Care Record, central pathology records alongside the adult and paediatric uveitis databases from 2011 to 2021. Patients were categorised into two groups using the Mandeville classification system. Standard Uveitis Nomenclature (SUN) was used to classify the uveitis. RESULTS: The population prevalence is at least 12.6 cases per million based on a population of 1.9 million. Nineteen of 24 cases were definite TINU and five of 24 probable. Seventeen out of 24 had biopsy-positive TIN, all of which met all of the Mandeville clinical diagnostic features required for a definite diagnosis. All but one presented with acute bilateral anterior uveitis. The paediatric cases ranged from age 12 to 18 at age of onset with a mean age of 14. Of the 18 adult onset cases, the age ranged from 20 to 76 years. The mean age of onset for the adult cases was 53 years. Of these patients 71% were female; 42% required second-line immunosuppression for ocular disease. Visual acuity was maintained. Follow-up time ranged from 3 months to 16 years. No patient developed long-term renal impairment. CONCLUSIONS: TINU is a cause of uveitis in both the paediatric and adult populations. In Northern Ireland average age with TINU was older than much of the published literature. Long-term immunosuppression for uveitis may be required as ongoing ocular, rather than renal inflammation seemed to require treatment.


Asunto(s)
Nefritis Intersticial , Uveítis Anterior , Uveítis , Enfermedad Aguda , Adolescente , Adulto , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nefritis Intersticial/diagnóstico , Nefritis Intersticial/tratamiento farmacológico , Nefritis Intersticial/epidemiología , Irlanda del Norte/epidemiología , Estudios Retrospectivos , Uveítis/diagnóstico , Uveítis/tratamiento farmacológico , Uveítis/epidemiología , Adulto Joven
11.
Hum Biol ; 82(5-6): 759-64, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21417894

RESUMEN

Academic research focusing on the population and culture history of the Aleut (Unangan) people began in the late 19th century and continues to the present. The papers in this special issue of Human Biology summarize the latest results from archaeological, linguistic, genetic, and morphometric research approaches that bear on our current understanding of Unangan history and prehistory. Although these new analyses have provided a level of description and resolution previously unattainable, explanatory models and mechanisms for the patterned variation observed over time in the biological and cultural record of the Aleutian region remains elusive. Bringing the diverse data sets into concordance to represent an integrated synthesis of Aleut population and culture history and of Unangan origins and their relationships with other groups in the region remains a goal for future investigators.


Asunto(s)
Genética de Población/estadística & datos numéricos , Inuk/genética , Alaska , Variación Genética , Historia Antigua , Humanos , Inuk/historia , Inuk/estadística & datos numéricos
12.
Science ; 205(4409): 901-2, 1979 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-17813082

RESUMEN

The low-temperature heat capacity behavior of naturally occuring water in Wyodak coal indicates that there are two types of water present. More than two-thirds is "nonfreezable," displaying no evidence of a phase transition in the neighborhood of 273 K where normal bulk water melts. The remainder is "freezable," displaying a somewhat distorted heat capacity peak, which is indicative of a phase transition. This evidence suggests that the nonfreezable water is either adsorbed on the internal surfaces of the coal or is in smaller pores, whereas the freezable water is in larger pores. Parallels to the heat capacity behavior of the coal-water system include the water in a porous ceramic, water in the mineral endellite, and water in the protein collagen.

13.
J Appl Microbiol ; 107(6): 2017-28, 2009 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-19583801

RESUMEN

AIM: To design a rapid diagnostic test to differentiate species belonging to the family Chlamydiaceae. METHODS AND RESULTS: Five oligonucleotide sets each targeting various conserved regions of the genome of six species (Chlamydia muridarum, C. suis, C. trachomatis, Chlamydophila felis, Cp. pneumoniae and Cp. psittaci) belonging to the family Chlamydiaceae were tested for their suitability for polymerase chain reaction (PCR) and high resolution melt (HRM) curve analysis to differentiate Chlamydiaceae species. Three of the oligonucleotide sets were able to detect all six reference species used in this study, but only one set (16SG) could clearly differentiate between them by HRM curve analysis. The PCR-HRM curve analysis confidence percentages correlated strongly with the nucleotide sequence identities. Clinical specimens from a number of animal species suspected of chlamydiosis were tested with the newly developed 16SG PCR-HRM curve analysis and sequenced to confirm the infecting species. It was demonstrated that PCR-HRM using the 16SG oligonucleotide set could relate the infecting Chlamydiaceae species to the most similar (based on 16S rRNA gene nucleotide sequence) reference species tested. Although Cp. pecorum was not included initially as a reference species in this assay, inclusion of a field isolate of Cp. pecorum as a reference allowed two koala specimens to be correctly identified. CONCLUSION: PCR-HRM analysis using the oligonucleotide set 16SG is a robust, simple and rapid technique for differentiation of at least the Chlamydiaceae species used in this study. SIGNIFICANCE AND IMPACT OF THE STUDY: This technique allowed for the rapid detection and identification of the six Chlamydiaceae reference species and may be useful for identification of uncharacterized Chlamydiaceae species or for use in animal species where occurrence of the disease has not been fully investigated.


Asunto(s)
Técnicas de Tipificación Bacteriana , Chlamydiaceae/clasificación , Chlamydiaceae/aislamiento & purificación , Hibridación de Ácido Nucleico/métodos , Reacción en Cadena de la Polimerasa/métodos , Animales , Secuencia de Bases , Chlamydiaceae/genética , Infecciones por Chlamydiaceae/microbiología , Infecciones por Chlamydiaceae/veterinaria , ADN Bacteriano/genética , Humanos , Datos de Secuencia Molecular , ARN Ribosómico 16S/genética , Alineación de Secuencia
14.
Ir Vet J ; 62 Suppl 4: S15-20, 2009 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-22082340

RESUMEN

Mastitis is still one of the three main diseases that affects the profitability of dairy farmers. Despite the implementation of the five-point mastitis control programme in the early 1970 s, the incidence in the UK has not reduced dramatically over the past 10 years. A review of the scientific literature indicates that there is a link between nutrition and mastitis in the dairy cow. The major impact of nutrition on udder health is via suppression of the immune system. Cows in negative energy balance are at a higher risk of ketosis and clinical ketosis is associated with a two-fold increase in the risk of clinical mastitis. Trace minerals and vitamins that can affect udder health are selenium and vitamin E, copper, zinc, and vitamin A and ß-carotene.

15.
Br J Cancer ; 99(12): 2054-64, 2008 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-19050703

RESUMEN

We sought to characterise whether dexamethasone (DEX) may enhance tumour response to docetaxel in in vitro and in vivo models of metastatic prostate cancer (CaP). In vitro experiments conducted on PC3 and human bone marrow endothelial cells (hBMECs) determined that administration of DEX (10 nM) reduced constitutive nuclear factor-kappaB (NF-kappaB) activity, decreasing interleukin (IL)-8, CXCL1 and VEGF gene expression in PC3 cells. Dexamethasone also attenuated docetaxel-induced NF-kappaB and activator protein-1 transcription and reduced docetaxel-promoted expression/secretion of IL-8 and CXCL1 in PC3 and hBMECs. Although DEX failed to enhance docetaxel cytotoxicity on PC3 cells, DEX potentiated the antiangiogenic activity of docetaxel in vitro, further reducing vessel area and vessel length in developing endothelial tubes (P<0.05). Docetaxel had a potent antiangiogenic activity in the dorsal skin flap-implanted PC3 tumours in vivo. Small blood vessel formation was further suppressed in tumours co-treated with docetaxel and DEX, substantiated by an increased average vessel diameter and segment length and a decreased number of branch points in the residual tumour vasculature (P<0.001). Our data show that DEX potentiates the antiangiogenic activity of docetaxel, suggesting a putative mechanism for the palliative and survival benefits of these agents in metastatic CaP.


Asunto(s)
Inhibidores de la Angiogénesis/farmacología , Dexametasona/farmacología , Orquiectomía , Neoplasias de la Próstata/irrigación sanguínea , Taxoides/farmacología , Animales , Línea Celular Tumoral , Docetaxel , Células Endoteliales/citología , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Humanos , Interleucina-8/biosíntesis , Interleucina-8/metabolismo , Masculino , Ratones , FN-kappa B/metabolismo , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , Taxoides/uso terapéutico , Factor de Transcripción AP-1/metabolismo , Ensayos Antitumor por Modelo de Xenoinjerto
17.
AJNR Am J Neuroradiol ; 28(9): 1683-9, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17893221

RESUMEN

BACKGROUND AND PURPOSE: Noninvasive grading of gliomas remains a challenge despite its important role in the prognosis and management of patients with intracranial neoplasms. In this study, we evaluated the ability of cerebral blood flow (CBF)-guided voxel-by-voxel analysis of multivoxel proton MR spectroscopic imaging ((1)H-MRSI) to differentiate low-grade from high-grade gliomas. MATERIALS AND METHODS: A total of 35 patients with primary gliomas (22 high grade and 13 low grade) underwent continuous arterial spin-labeling perfusion-weighted imaging (PWI) and (1)H-MRSI. Different regions of the gliomas were categorized as "hypoperfused," "isoperfused," and "hyperperfused" on the basis of the average CBF obtained from contralateral healthy white matter. (1)H-MRSI indices were computed from these regions and compared between low- and high-grade gliomas. Using a similar approach, we applied a subgroup analysis to differentiate low- from high-grade oligodendrogliomas because they show different physiologic and genetic characteristics. RESULTS: Cho(glioma (G)/white matter (WM)), Glx(G/WM), and Lip+Lac(G)/Cr(WM) were significantly higher in the "hyperperfused" regions of high-grade gliomas compared with low-grade gliomas. Cho(G/WM) and Lip+Lac(G)/Cr(WM) were also significantly higher in the "hyperperfused" regions of high-grade oligodendrogliomas. However, metabolite ratios from the "hypoperfused" or "isoperfused" regions did not exhibit any significant differences between high-grade and low-grade gliomas. CONCLUSION: The results suggest that (1)H-MRSI indices from the "hyperperfused" regions of gliomas, on the basis of PWI, may be helpful in distinguishing high-grade from low-grade gliomas including oligodendrogliomas.


Asunto(s)
Neoplasias Encefálicas/diagnóstico , Glioma/diagnóstico , Imagen por Resonancia Magnética/métodos , Espectroscopía de Resonancia Magnética/métodos , Adulto , Anciano , Diagnóstico por Computador/métodos , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Marcadores de Spin
18.
Nat Biotechnol ; 18(2): 194-8, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10657127

RESUMEN

Monoclonal antibodies specific for the p185HER2/neu growth factor receptor represent a significant advance in receptor-based therapy for p185HER2/neu-expressing human cancers. We have used a structure-based approach to develop a small (1.5 kDa) exocyclic anti-HER2/neu peptide mimic (AHNP) functionally similar to an anti-p185HER2/neu monoclonal antibody, 4D5 (Herceptin). The AHNP mimetic specifically binds to p185HER2/neu with high affinity (KD=300 nM). This results in inhibition of proliferation of p185HER2/neu-overexpressing tumor cells, and inhibition of colony formation in vitro and growth of p185HER2/neu-expressing tumors in athymic mice. In addition, the mimetic sensitizes the tumor cells to apoptosis when used in conjunction with ionizing radiation or chemotherapeutic agents. A comparison of the molar quantities of the Herceptin antibody and the AHNP mimetic required for inhibiting cell growth and anchorage-independent growth showed generally similar activities. The structure-based derivation of the AHNP represents a novel strategy for the design of receptor-specific tumor therapies.


Asunto(s)
Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/farmacología , Antineoplásicos/química , Imitación Molecular , Receptor ErbB-2/antagonistas & inhibidores , Animales , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Apoptosis , Astrocitoma , Técnicas Biosensibles , Doxorrubicina/uso terapéutico , Diseño de Fármacos , Quimioterapia Combinada , Rayos gamma , Ratones , Ratones Desnudos , Unión Proteica , Radioterapia Adyuvante , Trastuzumab , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/efectos de la radiación
19.
Ir Med J ; 100(4): 431-3, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17566478

RESUMEN

To retrospectively evaluate the efficacy of zonisamide as adjunctive therapy in the treatment of refractory juvenile myoclonic epilepsy. We retrospectively reviewed the records of seven patients with refractory juvenile myoclonic epilepsy, commenced on a compassionate-use basis on zonisamide as adjunctive treatment between October 2001 and September 2004. We found significant response rates (>50% reduction in seizure frequency) of 83.3%, 100% and 100% for generalised convulsions, myoclonus, and absence seizures respectively. These results were sustained over more prolonged follow-up in five of seven patients, with one patient improving further over time. Two patients became seizure free with the introduction of zonisamide. Two patients were able to reduce the number of anti-epileptic medications and maintain >75% and 100% reduction in seizure frequency respectively. Four patients initially had minor side-effects that resolved during the maintenance period. In this retrospective study, zonisamide was effective and well-tolerated as adjunctive therapy in patients with refractory juvenile myoclonic epilepsy.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Isoxazoles/uso terapéutico , Epilepsia Mioclónica Juvenil/tratamiento farmacológico , Resultado del Tratamiento , Adolescente , Adulto , Anticonvulsivantes/farmacología , Empatía , Femenino , Humanos , Irlanda , Isoxazoles/farmacología , Epilepsia Mioclónica Juvenil/fisiopatología , Recurrencia , Estudios Retrospectivos , Zonisamida
20.
Cancer Res ; 60(20): 5879-86, 2000 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-11059786

RESUMEN

Glioblastomas are highly vascular malignant brain tumors that often overexpress vascular endothelial growth factor (VEGF). They also frequently overexpress epidermal growth factor receptor (EGFR) and contain regions of hypoxia, both conditions that can induce VEGF. We examined VEGF regulation in U87 MG human glioblastoma cells and in U87/T691 cells, a clonal derivative that contains a truncated erbB2/Neu receptor that interferes with EGFR signaling through the formation of nonfunctional heterodimeric receptor complexes. U87/T691 cells contained approximately one-half as much VEGF mRNA as did U87 MG cells under normoxic conditions (21% oxygen). Pharmacological inhibition of EGFR, Ras, or PI(3) kinase, but not MAP kinase, led to a significant decrease in VEGF mRNA levels in U87 MG cells. VEGF promoter activity in transient transfections was decreased by either pharmacological or genetic inhibition of EGFR, Ras, or phosphatidylinositol 3'-kinase [PI(3) kinase]. However, inhibition of PI(3) kinase or EGFR did not completely abolish induction of VEGF mRNA by hypoxia (0.2% oxygen). Likewise, VEGF mRNA expression was induced 3-fold by hypoxia in EGFR-inhibited U87/T691 cells, comparable with the fold induction seen in parental U87 MG cells, although the absolute level of message under hypoxia was higher in U87 MG cells. In transient transfections, a luciferase reporter construct containing a 1.2-kb fragment of the VEGF promoter, lacking the known hypoxic-responsive element (HRE), showed up-regulation after EGF stimulation to the same degree as the full-length, 1.5-kb VEGF promoter construct retaining the HRE. Furthermore, activity of the HRE-deleted, 1.2-kb promoter luciferase reporter was down-regulated by PI(3) kinase inhibition. Therefore, in glioblastoma cells, transcriptional regulation of the VEGF promoter by EGFR appears to involve Ras/PI(3) kinase and to be distinct from signals induced by hypoxia.


Asunto(s)
Factores de Crecimiento Endotelial/biosíntesis , Receptores ErbB/fisiología , Glioblastoma/metabolismo , Linfocinas/biosíntesis , Metionina/análogos & derivados , Fosfatidilinositol 3-Quinasas/metabolismo , Hipoxia de la Célula/fisiología , Regulación hacia Abajo , Factores de Crecimiento Endotelial/genética , Inhibidores Enzimáticos/farmacología , Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/genética , Regulación Neoplásica de la Expresión Génica/fisiología , Glioblastoma/genética , Humanos , Linfocinas/genética , Metionina/farmacología , Proteínas Quinasas Activadas por Mitógenos/antagonistas & inhibidores , Inhibidores de las Quinasa Fosfoinosítidos-3 , Regiones Promotoras Genéticas/fisiología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptor ErbB-2/genética , Transducción de Señal/fisiología , Transcripción Genética , Células Tumorales Cultivadas , Regulación hacia Arriba , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial Vascular , Proteínas ras/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA